Association between telomere length in blood and mortality in people aged 60 years or older

Telomeres » Institutional Study » Association between telomere length in blood and mortality in people aged 60 years or older

April 28, 2017 | Amy | Leave a comment

Peer-Reviewed Scientific Journal:
Lancet

Size of study:
143 subjects over 60 years of age

Summary
This study assessed the association between blood leukocyte average telomere length and mortality in 143 normal unrelated individuals over the age of 60 years. Individuals with shorter telomeres had poorer survival, attributable in part to a 3.18-fold higher mortality rate from heart disease (95% CI 1(.)36-7.45, p=0.0079), and an 8.54-fold higher mortality rate from infectious disease (1.52-47.9, p=0.015). These results support that telomere shortening in human beings contributes to mortality in many age-related diseases.

Link to study

SEE THE FULL STUDY

Leave a Reply Cancel reply

The TeloYears test is not intended for screening, diagnosing, treating or preventing diseases or medical conditions. The TeloYears genetic test may indicate the possibility of identifying a rare telomere syndrome associated with extremely shorter or longer average telomere length (ATL). In these rare cases, further testing and consultation with a doctor to rule in or rule out a telomere syndrome is recommended. The test is available for individuals between the ages of 20 to 80 within the United States, except for the states of Maryland and New York. The information provided by the TeloYears test should not be used to replace medically appropriate screening tests recommended based upon actual age or other risk factors, nor should the information be used to make decisions about diagnosis or treatment of diseases or medical conditions. The Telomere Diagnostics lab is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by Telomere Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration.